11th Cir. Appeals in Zantac MDL Dismissed for Lack of Final Judgments




ATLANTA — A federal appellate panel has dismissed appeals filed by two individuals who allege their cancer was caused by their ingestion of contaminated Zantac (ranitidine), ruling that appellate jurisdiction is lacking because there was no final judgment issued by the MDL court that disposed of their claims.

In a Nov. 7 opinion, the 11th Circuit U.S. Court of Appeals explained that while it is possible that the claims remaining in the plaintiffs’ amended short form complaints, once paired with a pending master complaint, have little chance of surviving given the MDL court’s rulings, there is no final ruling putting …






UPCOMING CONFERENCES




HarrisMartin's New Jersey Asbestos Litigation Conference

March 03, 2023 - New Brunswick, NJ
Hyatt Regency New Brunswick

MORE DETAILS



HarrisMartin's MDL Conference: Managing Mass Torts, Status of Key Litigations and Lessons Learned

March 29, 2023 - Tucson, AZ
Omni Tucson National Resort

MORE DETAILS